Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Healthcare Stocks: Healthequity (HQY), Ionis Pharmaceuticals (IONS)

Tipranks - Tipranks - Tue Jan 20, 1:52AM CST

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Healthequity (HQY – Research Report) and Ionis Pharmaceuticals (IONS – Research Report) with bullish sentiments.

Claim 50% Off TipRanks Premium

Healthequity (HQY)

Bank of America Securities analyst Allen Lutz maintained a Buy rating on Healthequity on January 16 and set a price target of $125.00. The company’s shares closed last Friday at $85.37.

According to TipRanks.com, Lutz is a 5-star analyst with an average return of 12.9% and a 66.9% success rate. Lutz covers the Healthcare sector, focusing on stocks such as Definitive Healthcare Corp, Hims & Hers Health, and Envista Holdings. ;'>

Currently, the analyst consensus on Healthequity is a Moderate Buy with an average price target of $117.09, representing a 35.4% upside. In a report issued on January 7, J.P. Morgan also maintained a Buy rating on the stock with a $129.00 price target.

See the top stocks recommended by analysts >>

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).